Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial,
Introducing Oncotarget.
As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.
Publication Alerts
Subscribe to receive alerts once a paper has been published by Oncotarget.
Sonja M. Kessler, Eva Lederer, Stephan Laggai, Nicole Golob-Schwarzl, Kevan Hosseini, Johannes Petzold, Caroline Schweiger, Robert Reihs, Marlen Keil, Jens Hoffmann, Christian Mayr, Tobias Kiesslich, Martin Pichler, Kyung Sik Kim, Hyungjin Rhee, Young Nyun Park, Sigurd Lax, Peter Obrist, Alexandra K. Kiemer, Johannes Haybaeck
Published Sep 21, 2017 · Vol. 8, No. 52 · pp. 89736-89745
Byong Chul Yoo, Jun Hwa Lee, Kyung-Hee Kim, Weiwei Lin, Jong Heon Kim, Jong Bae Park, Hyun Jin Park, Sang Hoon Shin, Heon Yoo, Ji Woong Kwon, Ho-Shin Gwak
Published Sep 18, 2017 · Vol. 8, No. 60 · pp. 101203-101214